David Leppert, MD: Building a Foundation for Neurofilament Light
March 22nd 2019The therapeutic head of neuroinflammation and pain at Novartis spoke about his desire to work to a point where physicians can use NfL to monitor disease activity, make therapeutic decisions, and give perspective to patients.